Graphite delivers 4x return on sale of life sciences data platform Beacon
Graphite Capital has agreed the sale of life sciences data and workflow platform Beacon to Corten Capital, in a deal that is expected to deliver of 4x cash return on the firm’s original investment in Hanson Wade in 2019.
